Osteoprotective properties of a combination of HDBA complex and vitamins D3 and B6 (Osteo-Vit D3)

Download full text PDF
DOI: https://doi.org/10.29296/25419218-2020-01-08
Issue: 
1
Year: 
2020

I.A. Samylina(1), V.I. Strukov(2), E.V. Petrova(3), P.A. Poluboyarinov(4), N.V. Eremina2, A.V. Kotovsky(2), R.T. Galeeva(2), L.G. Radchenko(2) 1-I.M. Sechenov First Moscow State Medical University (Sechenov University), 4-2, Bolshaya Pirogovskaya St., Moscow 119991, Russian Federation; 2-Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, 8A, Stasov St., Penza 440060, Russian Federation; 3-Penza State University, 40, Krasnaya St., Penza 440026, Russian Federation; 4-Penza State University of Architecture and Construction, 28, German Titov St., Penza 440028, Russian Federation

The use of a number of drugs (including antibiotics) is accompanied by a higher risk of fractures, by the development of inflammatory joint diseases, and malfunctions of the immune and hematopoietic systems. Therefore, it is relevant to take drugs that are able to neutralize the negative effects of various drugs on the locomotor system and to safely restore bone strength in people of different age groups. These properties are available in the Russian osteobiotic Osteo-Vit D3, the intake of which is recommended to be combined with antibiotic therapy. There is evidence that the drug is able to neutralize the negative effects of various agents on the locomotor system and to safely restore bone strength in patients of any age. It is also important that the action of Osteo-Vit D3 is based on the activation of the body’s own reserves. The drug does not contain calcium, since it has long been established that fractures occur due to impaired metabolism of the mineral rather than its deficiency. The active ingredients of the osteobiotic Osteo-Vit D3, such as the HDBA organic complex (drone homogenate) that has a pronounced gonadotropic activity and stimulates endogenous testosterone, which contributes to hormonal balance restoration and collagen production; vitamin D3 that is able to set in motion the body’s own calcium reserves to increase bone mineral density; and vitamin B6 that can lower plasma homocysteine levels. The synergistic activity of these substances restores the body’s impaired metabolism of calcium, as well as its bone tissue retention. The protective effect of the osteobiotic also extends to the immune and hematopoietic systems. Osteo-Vit D3 positively affects the mechanisms of both innate and acquired immunity, supporting the normal functioning of the immune system, and improves hematopoiesis. If antibiotic therapy cannot be avoided, the osteobiotic will protect organs and tissues from this therapy and reduce the number of adverse reactions.
Keywords: 
Osteo-Vit D3
osteobiotic
antibiotics
References: 
  1. Hathaway-Schrader J.D., Steinkamp H.M., Chavez M. B., Poulides N.A., Kirkpatrick J.E., Chew M. E., Huang E., Alekseyenko A.V., Aguirre J.I., Novince C. M. Antibiotic Perturbation of Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development. American Journal of Pathology. 2019. Vol. 189 (2): 370–90.
  2. Horton D. Antibiotics in Children Increase Risk for Juvenile Arthritis. URL : https://www.medscape.com/viewarticle/835110
  3. Yeh M.W., Zhou H., Adams A.L., Ituarte P.H., Li N., Liu I.L., Haigh P.I. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study. Annals of Internal Medicine. 2016. Vol. 164 (11): 715–23.
  4. Durham S., Miller R., Davis C., Shepler B. M. Bisphosphonate Nephrotoxicity Risks and Use in CKD Patients. US Pharmacist. 2010. Vol. 35 (5)
  5. Dadykina I.S., Dadykina P.S., Murav'ev Ju.V. Osnovy izuchenija bezopasnosti lekarstvennyh sredstv. Spektr redkih i neozhidannyh neblagoprijatnyh reaktsij bisfosfonatov. Sovremennaja revmatologija. 2011; 4: 79–86. [Dadykina I.S., Dadykina P.S., MuravievYu.V.Fundamentals of the study of the safety of medicinal plants. The spectrum of rare and unexpected adverse effects of bisphosphonates. Sovremennaya revmatologiya. 2011; 4: 79–86] (in Russian).
  6. Rozhinskaja L.Ja. Diagnostika i lechenie osteoporoza. Klinicheskaja gerontologija. 2007; 2: 37–46. [RozhinskayaL.Ya. Diagnostics and treatment of osteoporosis. Klinicheskaya gerontologiya. 2007; 2: 37–46] (in Russian).
  7. Sharma A., Chatterjee S., Arbab-Zadeh A., Goyal S., Lichstein E., Ghosh J., Aikat S. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest. 2013. Vol. 144 (4): 1311–22.
  8. Nikitinskaja O. A., Toroptsova N. V., Benevolenskaja L. I. Rol' kal'tsija i vitamina D v profilaktike osteoporoza i svjazannyh s nim perelomov. Meditsinskij sovet. 2007; 2: 56–60. [Nikitinskaya O.A., Toroptsova N.V., Benevolenskaya L.I. The role of calcium and vitamin D in the prevention of osteoporosis and related fractures. Medicinskiy sovet. 2007; 2: 56–60] (in Russian).
  9. Bolland M. J., Avenell A., Baron J. A., Grey A., MacLennan G. S., Gamble G. D., Reid I. R. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. British Medical Jornal. 2010. Vol.  341: 3691.
  10. Curhan G. C., Willett W.C., Speizer F.E., Spiegelman D, Stampfer M. J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Annals of Internal Medicine. 1997. Vol. 126: 497–504.
  11. Baker M.J., Longyhore D.S. Dietary calcium, calcium supplements, and the risk of calcium oxalate kidney stones. American Journal of Health-System Pharmacy. 2006. Vol. 63 (8): 772–5.
  12. Jackson R.D., LaCroix A.Z., Gass M., Wallace R. B., Robbins J., Lewis C.E., Bassford T., Beresford S.A. et. al. Calcium plus vitamin D supplementation and the risk of fractures. New England Journal of Medicine. 2006. Vol. 354 (7): 669–83.
  13. Bolland M.J., Barber P.A., Doughty R.N., Mason B., Horne A., Ames R., Gamble G. D., Grey A., Reid I. R. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. British Medical Journal. 2008. Vol. 336: 262–6.
  14. Ahn J., Albanes D., Peters U., Schatzkin A., Lim U., Freedman M., Chatterjee N., Andriole G. L., Leitzmann M. F., Hayes R. B. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007. Vol. 16 (12): 2623–30.
  15. Peggy E. Link Between Dietary Calcium and Prostate Cancer Risk Becomes More Complex. Oncology Times. 2006. Vol. 28 (18): 36, 37.
  16. Straub D. A. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutrition in Clinical Practice. 2007. Vol. 22 (3): 286–96.
  17. Venchikov A. I. Biotiki: k teorii i praktike primenenija mikroelementov. 2-e izd., pererab. i dop. Ashhabad : Ylym, 1978: 279 s. [Venchikov A.I. Biotics: the theory and practice of the use of microelements. 2nded., revisedandenlarged. Ashkhabad: Ylym, 1978. 279 p.] (in Russian).
  18. Tok E. C., Ertunc D., Oz U., Camdeviren H., Ozdemir G., Dilek S. The effect of circulating androgens on bone mineral dencity in postmenopausal women. Maturitas. 2004. Vol. 48 (3): 35–242.
  19. Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiols effects on postmenopausal bone density and sexuality. Maturitas. 2008. Vol. 61: 17–26.
  20. Dolan S.E., Carpenter S., Grinspoon S. Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women. Journal of AIDS. 2007. Vol. 45 (2): 161–7.
  21. Buchanan J. R., Hospodar P., Myers C., Leuenberger P., Demers L.M. Effect of excess endogenous androgens on bone density in young women. Journal of Clinical Endocrinology and Metabolism. 1988. Vol. 67 (5): 937–43.
  22. Burmistrova L.A. Fiziko-himicheskij analiz i biohimicheskaja otsenka biologicheskoj aktivnosti trutnevogo rasploda. Dissertatsija na soiskanie uchenoj stepeni kandidata biologicheskih nauk: 03.00.04. Rjazan', 1999; 172 s. [Burmistrova L.A. Physicochemical analysis and biochemical evaluation of drone brood biological activity: thesis for the degree of candidate of biological sciences: 03.00.04. - Ryazan, 1999. - 172 p. (in Russian) ]
  23. Strukov V. I., Dzhons O., Krutjakov E. N., Elistratov K. G. Sposob i preparat dlja profilaktiki i lechenija atipichnogo osteoporoza s normal'noj ili povyshennoj mineralizatsiej kostnoj tkani s nalichiem polostnyh obrazovanij v trabekuljarnyh otdelah kostej (i emu blizkih sostojanijah pri izbytochnoj masse i metabolicheskom sindrome) : patent na izobretenie RU 2497533. – 2013. URL: http://www.freepatent.ru/images/patents/495/2497533/patent-2497533.pdf [Strukov V. I., Jones O., Krutyakov E. N., Elistratov K. G. Method and preparation for the prevention and treatment of atypical osteoporosis characterized by normal or increased mineralization of bone tissue and presence of cavities in trabecular parts of bones (and similar cases characterized by excess weight and metabolic syndrome): patent for the invention RU 2497533. - 2013. URL: http://www.freepatent.ru/images/patents/495/2497533/patent-2497533.pdf (in Russian)].
  24. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. –Washington, DC: National Academy Press, 2010.
  25. Holick M. F., Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. ed. Favus M. J. Washington, DC: American Society for Bone and Mineral Research, 2006: 129–37.
  26. Bouillon R. Vitamin D: from photosynthesis, metabolism, and action to clinical applications. Endocrinology. eds. DeGroot L. J., Jameson J. L. Philadelphia : W.B. Saunders, 2001: 1009–28.
  27. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. American Journal of Clinical Nutrition. 2004. Vol. 80: 1689–96.
  28. Heaney R.P., Dowell M.S., Hale C.A., Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal of the American College of Nutrition. 2003. Vol. 22: 142–6.
  29. Strukov V.I., Bolohonova G.A. Prichiny gipervitaminoza D u detej. Zdravoohranenie Kazahstana. 1972; 10. [Strukov V.I., Balakhonova G.A. Causes of hypervitaminosis D in children. Zdravoohranenie Kazahstana 1972; 10 (in Russian)].
  30. Boyan B. D., Hyzy S. L., Pan Q., Scott K. M. , Coutts R. D. , Healey R., Schwartz Z. 24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats. PLoS One. 2016. Vol. 11 (8).
  31. Dankers W., Colin E. M., van Hamburg J. P., Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Frontiers in Immunology. 2016. Vol. 7: 697.
  32. Massé P.G., Pritzker K., Mendes M.G., Boskey A.L. Vitamin B6 deficiency experimentally-induced bone and joint disorder: Microscopic, radiographic and biochemical evidence. British Journal of Nutrition. 1994. Vol. 71 (6): 919–32.
  33. Rondanelli M., Opizzi A., Perna S., Faliva M. A. Update on nutrients involved in maintaining healthy bone. Endocrinología y Nutrición. 2013. Vol. 60: 197–210.
  34. Gromova O. A., Torshin I. Ju., Limanova O. A. Kal'tsij i ego sinergisty v podderzhke struktury soedinitel'noj i kostnoj tkani. Lechaschij vrach. 2014; 5: 2–7. [Gromova O. A., Torshin I. Yu., Limanova O. A. Calcium and its synergists to support the structure of connective and bone tissue. Lechashhiy vrach. 2014; 5: 2–7 (in Russian)].
  35. Holstein J. H., Herrmann M., Splett C., Herrmann W., Garcia P., Histing T. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. American Journal of Clinical Nutrition. 2009. Vol. 90: 1440–5.
  36. McLean R.R., Jacques P.F., Selhub J. Plasma B Vitamins, Homocysteine, and their relation with bone loss and hip fracture in elderly men and women. Journal of Clinical Endocrinology and Metabolism. 2008. Vol. 93: 2206–12.
  37. Feskanich D., Willett W. C., Stampfer M. J., Colditz G. A. Milk, dietary calcium, and bone fractures in women: a 12-year prospective study. American Journal of Public Health. 1997. Vol. 87 (6): 992–7.
  38. Owusu W., Willett W. C., Feskanich D., Ascherio A., Spiegelman D., Colditz G. A. Calcium intake and the incidence of forearm and hip fractures among men. Journal of Nutrition. 1997. Vol. 127 (9): 1782–7.
  39. Strukov V.I., Elistratov D.G., Scherbakova Ju.G., Kuptsova T.A., Galeeva R.T., Radchenko L.G., Maksimova M.N. «Osteo-Vit D3» v lechenii i profilaktike povtornyh perelomov u detej s nizkoj mineral'noj plotnost'ju kostnoj tkani. Meditsinskaja sestra. 2014; 7: 44–6. [Strukov V.I., Elistratov D.G., Shherbakova Yu.G., Kuptsova T.A., Galeeva R.T., Radchenko L.G., Maksimova M.N. «Osteo-Vit D3» in treatment and prevention of repeated fractures in children having low bone mineral density. Meditsinskaya sestra. 2014; 7: 44–6 (in Russian)].
  40. Kuptsova T.A. , Vasilistov D.B. , Agafonov D.V. Problema otryvnyh perelomov u sportsmenov-podrostkov na klinicheskom primere. Teorija i praktika sozdanija trenazherov: nakoplenie i obrabotka informatsii, informatsionnye modeli, sredstva informatizatsii. Materialy mezhdunarodnoj konferentsii, vyp. 1. Penza: Penzenskij gosudarstvennyj tehnologicheskij universitet, 2015: 102–5. [Kuptsova T.A., Vasilistov D.B., Agafonov D.V. The problem of avulsion fractures in adolescent athletes based on a clinical example. Theory and practice of creating simulators: information accumulation and processing, information models, means of informatization: proceedings of the international conference, issue 1. Penza: Penza State Technological University, 2015: 102–5 (in Russian)].
  41. Polikarpochkin A.N., Levshin I.V., Vovk E.V., Strukov V.I., Raskachkin V.A., Tokarev A.V. Otsenka effektivnosti primenenija giperbaricheskoj oksigenatsii i preparata «Osteo-Vit D3» pri lechenii gonartrozov. Giperbaricheskaja fiziologija i meditsina. 2018; 1: 13–24. [Polikarpochkin A.N., Levshin I.V., Vovk E.V., Strukov V.I., Raskachkin V.A., Tokarev A.V. Evaluation of the effectiveness of hyperbaric oxygenation and preparation «Osteo-Vit D3» in the treatment of gonarthrosis. Giperbaricheskaya fiziologiya i meditsina. 2018; 1: 13–24 (in Russian)].
  42. Pigarova E.A., Plescheva A.V., Dzeranova L.K. Vlijanie vitamina D na immunnuju sistemu. Immunologija. 2015; 1: 62–6. [Pigarova E.A., Pleshheva A.V., Dzeranova L.K. Vitamin D influence on the immune system. Immunologiya. 2015; 1: 62–6 (in Russian)].
  43. Abaturov A.E., Zavgorodnjaja N.Ju. Vitamin-D-zavisimaja produktsija antimikrobnyh peptidov. Klinichni lektsiї. 2012; 1 (36): 105–111. [Abaturov A. E., Zavgorodnyaya N. Yu. Vitamin-D influence on the antimicrobial peptides production. Klinichni lektsii. 2012 1 (36): 105–111 (in Russian)]. Georgieva V., Kamolvit W., Herthelius M., Lüthje P., Brauner A., Chromek M. Association Between Vitamin D, Antimicrobial Peptides and Urinary Tract Infection in Infants and Young Children. Acta Paediatrica. 2019. Vol. 108 (3): 551–6.
  44. Klishina I. I. Vlijanie trutnevogo rasploda na aktivnost' faktorov nespetsificheskoj rezistentsii i funktsional'noe sostojanie pecheni pri ostroj intoksikatsii. Dissertatsija na soiskanie uchenoj stepeni kandidata farmatsevticheskih nauk : 14.00.25. Pjatigorskaja gosudarstvennaja farmatsevticheskaja akademija. Pjatigorsk, 2003. [Klishina I.I. Drone brood influence on the activity of nonspecific resistance factors and liver functional state in case of acute intoxication: thesis for the degree of candidate of pharmaceutical sciences: 14.00.25. Pyatigorsk State Pharmaceutical Academy. Pyatigorsk, 2003 (in Russian)].
  45. Leklem J.E. Vitamin B6. Modern Nutrition in Health and Disease. eds. Shils M., Olson J.A., Shike M., Ross A.C. 9th ed. Baltimore : Williams & Wilkins, 1999: 413–22.